This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

What Can You Expect?

Björn Stenkvist, MD; Roland Bergström, MD; Gunnar Eklund, PhD; Cecil H. Fox

JAMA. 1984;252(11):1423-1426.

Abstract
More than 90% of the total female population of three Swedish counties between the ages of 30 and 59 years, 53% of women between 60 and 69 years, and 25% of women older than 70 years were screened for cervical cancer with the Papanicolaou smear over a ten-year period. The uniqueness of the study is that in Sweden it is possible to follow up the entire population during their lifetimes via a population register, which has its roots in the 17th century, natural to Swedes but almost incomprehensible in the United States or United Kingdom. Every Papanicolaou smear taken was computer recorded and linked on an individual level to the cancer registry. There were 207,455 women followed up for ten years. No women were lost to follow-up. There was a 75% decrease in invasive cervical cancer incidence among women who had smears taken at least once during the ten-year period. Among those women who had never had smears taken, the incidence of invasive cervical cancer was four times as great as among those women who had been examined at least once. We estimate that the system proposed by Swedish Medical Board (at least one smear every three years) for cervical cancer screening can reduce the incidence of invasive cervical cancer to a level between one and five cases per 100,000 women per year in a completely screened population.

(JAMA 1984;252:1423-1426)

Author Affiliations
From the Department of Clinical Cytology, University Hospital, Uppsala, Sweden (Dr Stenkvist); the Department of Pathology, Ostersund Hospital, Östersund, Sweden (Dr Bergström); the Institute for Cancer Epidemiology, Karolinska Institute, Stockholm (Dr Eklund); and the Division of Cancer Biology and Diagnosis, National Cancer Institute, Bethesda, Md (Mr Fox).

Footnotes
Reprint requests to Department of Clinical Cytology, University Hospital, S-751 85 Uppsala, Sweden (Dr Stenkvist).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Does gel affect cytology or comfort in the screening papanicolaou smear?
Gilson et al.
J Am Board Fam Med 2006;19:340-344.
ABSTRACT | FULL TEXT  

Is the Promise of Cancer-Screening Programs Being Compromised? Quality of Follow-Up Care after Abnormal Screening Results
Yabroff et al.
Med Care Res Rev 2003;60:294-331.
ABSTRACT  

Cost Effectiveness of Cervical Cancer Screening for the Elderly
Fahs et al.
ANN INTERN MED 1992;117:520-527.
ABSTRACT  

Quality Assurance in Cervical Cytology: The Papanicolaou Smear
Council on Scientific Affairs
JAMA 1989;262:1672-1679.
ABSTRACT  

Papanicolaou Smear Testing in Elderly Women-Reply
Mandelblatt et al.
JAMA 1986;256:2819-2820.
ABSTRACT  

Gynecological Care of Elderly Women: Another Look at Papanicolaou Smear Testing
Mandelblatt et al.
JAMA 1986;256:367-371.
ABSTRACT